CLBFX
Price
$40.96
Change
+$0.10 (+0.24%)
Updated
Jun 2 closing price
Net Assets
278.87B
SVBCX
Price
$32.28
Change
+$0.19 (+0.59%)
Updated
Jun 2 closing price
Net Assets
6.9B
Interact to see
Advertisement

CLBFX vs SVBCX

Header iconCLBFX vs SVBCX Comparison
Open Charts CLBFX vs SVBCXBanner chart's image
CLBFX vs SVBCX Comparison Chart in %
View a ticker or compare two or three
VS
CLBFX vs. SVBCX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLBFX is a Hold and SVBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CLBFX has more cash in the bank: 279B vs. SVBCX (6.9B). CLBFX pays higher dividends than SVBCX: CLBFX (1.92) vs SVBCX (0.86). CLBFX was incepted earlier than SVBCX: CLBFX (24 years) vs SVBCX (27 years). SVBCX (1.73) is less costly to investors than CLBFX (0.66). SVBCX is a more actively managed with annual turnover of: 71.00 vs. CLBFX (50.00). CLBFX has a lower initial minimum investment than SVBCX: CLBFX (250) vs SVBCX (1000). CLBFX annual gain was more profitable for investors over the last year : 17.91 vs. SVBCX (11.59). CLBFX return over 5 years is better than : 38.25 vs. SVBCX (28.65).
CLBFXSVBCXCLBFX / SVBCX
Total Expense Ratio0.661.7238%
Annual Report Gross Expense Ratio0.661.7338%
Fund Existence24 years27 years-
Gain YTD9.7869.614102%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets279B6.9B4,046%
Annual Yield % from dividends1.920.86224%
Returns for 1 year17.9111.59155%
Returns for 3 years46.1736.61126%
Returns for 5 years38.2528.65134%
Returns for 10 years101.6389.68113%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PQSCX22.12N/A
N/A
Virtus KAR Small-Cap Value C
HOORX31.13N/A
N/A
Hartford Schroders US Small Cap Opps R3
AMVYX15.88N/A
N/A
American Century Mid Cap Value Y
MEMSX12.15N/A
N/A
Mercer Emerging Markets Equity I
MSVOX6.61N/A
N/A
Morgan Stanley Vitality Portfolio R6